Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.95 +0.25%
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($1.36), $0.16 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $75.23 million versus the consensus estimate of $52.66 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carnival Corp. (CCL) call put ratio 4.6 calls to 1 put with a focus on with a focus on September 4 weekly 24.50 calls as share price up 2.7%
- United Airlines (UAL) call put ratio 1.5 calls to 1 put with a focus on September 4 weekly options
- Viking (VIK) 1K contracts of October 90 calls trade, share price up 2.1%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
